250 mg erythromycin side effects price claritin 40 mg propranolol side effects seroquel effects on liver buy metformin uk desyrel 30 mg online cialis prescription meclizine hydrochloride price where can i buy remeron advair 25050 vs symbicort mestinon timespan 180 mg price nitrofurantoin 50mg dosage order motrin samples 1100 mg of aleve side effects of zetia cholesterol medicine generic for avapro 150 mg mail order flonase micardis price increase benicar 20125 skelaxin 800 mg cost metoclopramide natural alternative just starting lexapro side effects side effects of bystolic 5 mg tablets generic actos generic alphagan p aceon 2mg ciplox 750 liv 52 syrup 200ml pills doxycycline hyclate buy clomid online cheap where can i purchase tamoxifen side effects of uroxatral toprol 50 mg xl crestor coupon mail order noroxin norfloxacin generic generic phenergan pill identifier himcolin gel usage side effects price rhinocort levitra 20 milligrams fluoxetine 80 mg day side effects artane order suhagra online valtrex price uk 4 mg estrace lasix effects kidneys when is sustiva going generic paxil 30 mg online cialis prescription noroxin side effects muscle pain order suhagra online yasmin pills usa generic name for motrin malegra pro 50 lexapro buy generic side effects tegretol generic ceftin side effects prednisone and sleeping pills lasix 80 mg od and parkinson’s disease buy diflucan single dose bactrim prescription DGHM – Dalton, Greiner, Hartman, Maher & Co., LLC
  • teamSlide01

  • processSlide02

  • serviceSlide01

  • alphaSlide01

DGHM employs a fundamental, value-driven investment philosophy that focuses specifically on domestic equity across the market capitalization spectrum.
Our team of 10 Sector Specialists combines quantitative tools with rigorous fundamental analysis. These specialists are experts in their fields and utilize a time-tested, disciplined approach to purchase high quality companies at compelling valuations.
We are committed to value creation over the long term. We strive for consistent alpha generation, yielding superior risk-adjusted results across our product line. Established in 1982, DGHM currently manages $1.9 billion in assets.

Our goal is to be a leading practitioner of fundamental analysis, with a product lineup that achieves highly competitive risk-adjusted returns for our clients over the long term.

We employ dedicated, passionate individuals who are incentivized to achieve outstanding performance and make significant contributions to the team’s efforts.

The heart of our process is in-depth fundamental research. We place our active weights in a manner to derive alpha from stock selection and empower our Sector Specialists with decision-making authority.

Our team of 10 Sector Specialists implements seven value-oriented investment strategies that span the entire market capitalization spectrum.